Efficacy of Totalfill® and ProRoot MTA® as Pulpotomy Agent in Primary Molars

• Status: Completed
• Trial end date: 2020-12-31
• Target enrollment: 0
• Participant gender: All

Summary

An experimental prospective double-blind, randomized clinical trial (RCT) with parallel design. To evaluate the outcome of using 2 pulpotomy agents: Totalfill® as study group and mineral trioxide aggregate (MTA®) as a control.

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: University Ghent

Criteria

Inclusion Criteria:

1. Patient inclusion criteria

• ASA 1 patient, Patient is a completely healthy & fit. No allergy or medical conditions.

• Patient is indicated for treatment under General Anesthesia: young age, uncooperative and extensive treatment plan.

• Parent agreed to participate in the study, and signed the written consent.

• Patient attended the out-patients pediatric dental clinic in UZ Gent.

2. Tooth inclusion criteria 2.1. Clinical inclusion criteria:

• Vital primary molars (first or second) with deep caries cavity with pulpal exposure.

• Only mandibular primary molar were included

• No spontaneous pain

• No history of swelling

• No sinus tract/ fistula

• Absent of tenderness in percussion

• No pathological mobility

• Restorable tooth (stainless steel crown can be placed)

• Hemostasis can be achieved with a dry cotton pellet after removal of Coronal pulp.

2.2. Radiographical inclusion criteria:

• At least 2/3rd of root is present

• Absence of internal or external root resorption

• Absence of pathologic root resorption

• Absence of periapical or furcation radiolucency

Exclusion Criteria:

If one or more of the criteria mentioned above is not fulfilled, the teeth were excluded from the study.